Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects
- PMID: 40828197
- DOI: 10.1007/s00204-025-04150-9
Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects
Erratum in
-
Correction: Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects.Arch Toxicol. 2025 Dec;99(12):4907. doi: 10.1007/s00204-025-04201-1. Arch Toxicol. 2025. PMID: 41003773 No abstract available.
Abstract
The cGAS-STING pathway, a crucial cytosolic DNA sensor, initiates innate immune responses by detecting microbial and aberrant self-DNA. This evolutionarily conserved axis plays pivotal roles in autoimmune disorders, sterile inflammation, and cellular senescence. While transient activation confers protective immunity, dysregulated cGAS-STING signaling drives pathogenesis in inflammatory and autoimmune diseases. Emerging evidence reveals its functional convergence with diverse cell death modalities-notably ferroptosis, an iron-dependent regulated cell death driven by lipid peroxidation. Their dynamic interplay emerges as a key pathogenic mechanism across diseases, offering novel therapeutic opportunities. This review first outlines the core molecular architecture of cGAS-STING signaling and its disease roles. We then analyze the mechanisms and pathophysiological consequences of cGAS-STING-ferroptosis crosstalk in various disorders, followed by advances in therapeutic strategies targeting this interface. Finally, we discuss translational challenges and propose innovative solutions. By highlighting the therapeutic potential of pharmacologically modulating this nexus, we identify a promising treatment for diseases with inflammatory conditions.
Keywords: Antagonist; Ferroptosis; Inhibitor; Interplay; cGAS-STING.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors have no competing financial or nonfinancial interests to disclose. Ethical approval and consent to participation: Not applicable. Consent for publication: Not applicable.
References
-
- Bao WD, Pang P, Zhou XT et al (2021) Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ 28(5):1548–1562. https://doi.org/10.1038/s41418-020-00685-9 - DOI - PubMed - PMC
-
- Bersuker K, Hendricks JM, Li Z et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688–692. https://doi.org/10.1038/s41586-019-1705-2 - DOI - PubMed - PMC
-
- Chen PH, Wu J, Ding CC et al (2020) Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ 27(3):1008–1022. https://doi.org/10.1038/s41418-019-0393-7 - DOI - PubMed
-
- Chen X, Kang R, Kroemer G, Tang D (2021a) Ferroptosis in infection, inflammation, and immunity. J Exp Med 218(6):e20210518. https://doi.org/10.1084/jem.20210518 - DOI - PubMed - PMC
-
- Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021b) Ferroptosis: machinery and regulation. Autophagy 17(9):2054–2081. https://doi.org/10.1080/15548627.2020.1810918 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
